Celiac disease increases the risk of toxoplasma gondii infection in a large cohort of pregnant women

American Journal of Gastroenterology

Volumn 106, Issue 3, 2011, Pages 548-549

  Nejad, Mohammad Rostami ^a   Rostami, Kamran ^b   Cheraghipour, Koroush ^c   Mojarad, Ehsan Nazemalhosseini ^a   Volta, Umberto ^d   Dulaimi, David Al ^e   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 8; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION RATE; INFECTION RISK; LETTER; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; SPONTANEOUS ABORTION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADULT; CELIAC DISEASE; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; IRAN; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 79952354895     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.425     Document Type: Letter

References (5)

1. Jackson EL, Hamlin PJ, Ford AC et al. VSL # 3 and remission in active ulcerative colitis: larger studies required. Am J Gastroenterol 2011;106:547 (this issue).
2. Tursi A, Brandimarte G, Papa A et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL # 3 as adjunctive to a standard pharmaceutical treatment: a doubleblind, randomized, placebo-controlled study. Am J Gastroenterol 2010;105:2218-27.
3. Rosado JL, Lopez P, Morales M et al. Fiber digestibility and breath-hydrogen excretion in subjects consuming rural and urban Mexican diets. Am J Clin Nutr 1991;53:55-60. (Pubitemid 21917607)
4. Sood A, Midha V, Makharia GK et al. The probiotic preparation VSL # 3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009;7:1202-9.
5. Orlando A, Armuzzi A, Papi C et al. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Digest Liver Dis;doi:10.1016/j.dld.2010.07.010 (in press).